{
  "ticker": "AMGN",
  "last_updated": "2025-04-19T07:50:06.454979",
  "retention_years": 3,
  "count": 186,
  "transactions": [
    {
      "id": 50856,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "HOLLEY CHARLES M",
      "reporting_owner_cik": "0001216478",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-31",
      "transaction_shares": "719",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "9574.0209"
    },
    {
      "id": 50857,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "ECKERT ROBERT",
      "reporting_owner_cik": "0001194256",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-31",
      "transaction_shares": "719",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "23715"
    },
    {
      "id": 50873,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Garland Greg C.",
      "reporting_owner_cik": "0001503107",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-31",
      "transaction_shares": "719",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "12374"
    },
    {
      "id": 50885,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "MILES AMY E",
      "reporting_owner_cik": "0001248617",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-31",
      "transaction_shares": "719",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "3927"
    },
    {
      "id": 50892,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Druker Brian",
      "reporting_owner_cik": "0001740205",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-31",
      "transaction_shares": "719",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "6472"
    },
    {
      "id": 50895,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Austin Wanda M",
      "reporting_owner_cik": "0001690882",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-31",
      "transaction_shares": "719",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "6544"
    },
    {
      "id": 50898,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Jacks Tyler",
      "reporting_owner_cik": "0001464237",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-31",
      "transaction_shares": "719",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "16005"
    },
    {
      "id": 50902,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Klotman Mary E.",
      "reporting_owner_cik": "0002020575",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-31",
      "transaction_shares": "719",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "719"
    },
    {
      "id": 50907,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Kullman Ellen Jamison",
      "reporting_owner_cik": "0001303141",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-31",
      "transaction_shares": "719",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "12299.9807"
    },
    {
      "id": 50909,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "ISHRAK OMAR",
      "reporting_owner_cik": "0001523102",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-31",
      "transaction_shares": "719",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "4695.6673"
    },
    {
      "id": 50918,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Drake Michael V",
      "reporting_owner_cik": "0001938942",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-31",
      "transaction_shares": "719",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "3174.7662"
    },
    {
      "id": 32871,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradway Robert A",
      "reporting_owner_cik": "0001396482",
      "reporting_owner_position": "Chairman, CEO and President",
      "transaction_date": "2024-05-07",
      "transaction_shares": "11988",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "669269"
    },
    {
      "id": 32875,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Grygiel Nancy A.",
      "reporting_owner_cik": "0001816414",
      "reporting_owner_position": "SVP & CCO",
      "transaction_date": "2024-05-07",
      "transaction_shares": "499",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "10300"
    },
    {
      "id": 32881,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Gordon Murdo",
      "reporting_owner_cik": "0001642156",
      "reporting_owner_position": "EVP, Global Commercial Ops",
      "transaction_date": "2024-05-07",
      "transaction_shares": "3529",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "52674"
    },
    {
      "id": 32887,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Santos Esteban",
      "reporting_owner_cik": "0001677950",
      "reporting_owner_position": "EVP, Operations",
      "transaction_date": "2024-05-07",
      "transaction_shares": "2997",
      "transaction_price": "300.30",
      "transaction_type": "A",
      "shares_after_transaction": "71304"
    },
    {
      "id": 32902,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Busch Matthew C.",
      "reporting_owner_cik": "0001987926",
      "reporting_owner_position": "VP, Finance & CAO",
      "transaction_date": "2024-05-07",
      "transaction_shares": "333",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "4932"
    },
    {
      "id": 32903,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "HOLLEY CHARLES M",
      "reporting_owner_cik": "0001216478",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-07",
      "transaction_shares": "141.5251",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8855.0209"
    },
    {
      "id": 32909,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Khosla Rachna",
      "reporting_owner_cik": "0001881332",
      "reporting_owner_position": "SVP, Business Development",
      "transaction_date": "2024-05-07",
      "transaction_shares": "532",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8559"
    },
    {
      "id": 32916,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Miller Derek",
      "reporting_owner_cik": "0001917312",
      "reporting_owner_position": "SVP, Human Resources",
      "transaction_date": "2024-05-07",
      "transaction_shares": "865",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8983"
    },
    {
      "id": 32920,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Griffith Peter H.",
      "reporting_owner_cik": "0001798821",
      "reporting_owner_position": "EVP & CFO",
      "transaction_date": "2024-05-07",
      "transaction_shares": "3196",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "35973"
    },
    {
      "id": 32922,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "ISHRAK OMAR",
      "reporting_owner_cik": "0001523102",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-07",
      "transaction_shares": "116.5501",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "3976.6673"
    },
    {
      "id": 32925,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Drake Michael V",
      "reporting_owner_cik": "0001938942",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-07",
      "transaction_shares": "116.5501",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "2455.7662"
    },
    {
      "id": 32927,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradner James E.",
      "reporting_owner_cik": "0002005159",
      "reporting_owner_position": "EVP, R&D, & Chief Sci. Officer",
      "transaction_date": "2024-05-07",
      "transaction_shares": "2863",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "25438"
    },
    {
      "id": 32928,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "REESE DAVID M",
      "reporting_owner_cik": "0001748434",
      "reporting_owner_position": "EVP & Chief Technology Officer",
      "transaction_date": "2024-05-07",
      "transaction_shares": "3196",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "61889"
    },
    {
      "id": 32931,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Graham Jonathan P",
      "reporting_owner_cik": "0001365306",
      "reporting_owner_position": "EVP & Gen. Counsel & Secy.",
      "transaction_date": "2024-05-07",
      "transaction_shares": "2863",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "35186"
    },
    {
      "id": 50842,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradway Robert A",
      "reporting_owner_cik": "0001396482",
      "reporting_owner_position": "Chairman, CEO and President",
      "transaction_date": "2024-05-07",
      "transaction_shares": "11988",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "669269"
    },
    {
      "id": 50846,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Grygiel Nancy A.",
      "reporting_owner_cik": "0001816414",
      "reporting_owner_position": "SVP & CCO",
      "transaction_date": "2024-05-07",
      "transaction_shares": "499",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "10300"
    },
    {
      "id": 50852,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Gordon Murdo",
      "reporting_owner_cik": "0001642156",
      "reporting_owner_position": "EVP, Global Commercial Ops",
      "transaction_date": "2024-05-07",
      "transaction_shares": "3529",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "52674"
    },
    {
      "id": 50860,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Santos Esteban",
      "reporting_owner_cik": "0001677950",
      "reporting_owner_position": "EVP, Operations",
      "transaction_date": "2024-05-07",
      "transaction_shares": "2997",
      "transaction_price": "300.30",
      "transaction_type": "A",
      "shares_after_transaction": "71304"
    },
    {
      "id": 50876,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Busch Matthew C.",
      "reporting_owner_cik": "0001987926",
      "reporting_owner_position": "VP, Finance & CAO",
      "transaction_date": "2024-05-07",
      "transaction_shares": "333",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "4932"
    },
    {
      "id": 50877,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "HOLLEY CHARLES M",
      "reporting_owner_cik": "0001216478",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-07",
      "transaction_shares": "141.5251",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8855.0209"
    },
    {
      "id": 50883,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Khosla Rachna",
      "reporting_owner_cik": "0001881332",
      "reporting_owner_position": "SVP, Business Development",
      "transaction_date": "2024-05-07",
      "transaction_shares": "532",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8559"
    },
    {
      "id": 50891,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Miller Derek",
      "reporting_owner_cik": "0001917312",
      "reporting_owner_position": "SVP, Human Resources",
      "transaction_date": "2024-05-07",
      "transaction_shares": "865",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8983"
    },
    {
      "id": 50897,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Griffith Peter H.",
      "reporting_owner_cik": "0001798821",
      "reporting_owner_position": "EVP & CFO",
      "transaction_date": "2024-05-07",
      "transaction_shares": "3196",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "35973"
    },
    {
      "id": 50900,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "ISHRAK OMAR",
      "reporting_owner_cik": "0001523102",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-07",
      "transaction_shares": "116.5501",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "3976.6673"
    },
    {
      "id": 50904,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Drake Michael V",
      "reporting_owner_cik": "0001938942",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-07",
      "transaction_shares": "116.5501",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "2455.7662"
    },
    {
      "id": 50906,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradner James E.",
      "reporting_owner_cik": "0002005159",
      "reporting_owner_position": "EVP, R&D, & Chief Sci. Officer",
      "transaction_date": "2024-05-07",
      "transaction_shares": "2863",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "25438"
    },
    {
      "id": 50908,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "REESE DAVID M",
      "reporting_owner_cik": "0001748434",
      "reporting_owner_position": "EVP & Chief Technology Officer",
      "transaction_date": "2024-05-07",
      "transaction_shares": "3196",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "61889"
    },
    {
      "id": 50912,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Graham Jonathan P",
      "reporting_owner_cik": "0001365306",
      "reporting_owner_position": "EVP & Gen. Counsel & Secy.",
      "transaction_date": "2024-05-07",
      "transaction_shares": "2863",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "35186"
    },
    {
      "id": 32874,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Graham Jonathan P",
      "reporting_owner_cik": "0001365306",
      "reporting_owner_position": "EVP & Gen. Counsel & Secy.",
      "transaction_date": "2024-05-05",
      "transaction_shares": "632",
      "transaction_price": "311.29",
      "transaction_type": "F",
      "shares_after_transaction": "32323"
    },
    {
      "id": 32876,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Gordon Murdo",
      "reporting_owner_cik": "0001642156",
      "reporting_owner_position": "EVP, Global Commercial Ops",
      "transaction_date": "2024-05-05",
      "transaction_shares": "665",
      "transaction_price": "311.29",
      "transaction_type": "F",
      "shares_after_transaction": "49145"
    },
    {
      "id": 32882,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Santos Esteban",
      "reporting_owner_cik": "0001677950",
      "reporting_owner_position": "EVP, Operations",
      "transaction_date": "2024-05-05",
      "transaction_shares": "617",
      "transaction_price": "311.29",
      "transaction_type": "F",
      "shares_after_transaction": "68307"
    },
    {
      "id": 32883,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Khosla Rachna",
      "reporting_owner_cik": "0001881332",
      "reporting_owner_position": "SVP, Business Development",
      "transaction_date": "2024-05-05",
      "transaction_shares": "41",
      "transaction_price": "311.29",
      "transaction_type": "F",
      "shares_after_transaction": "8027"
    },
    {
      "id": 32885,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Busch Matthew C.",
      "reporting_owner_cik": "0001987926",
      "reporting_owner_position": "VP, Finance & CAO",
      "transaction_date": "2024-05-05",
      "transaction_shares": "27",
      "transaction_price": "311.29",
      "transaction_type": "F",
      "shares_after_transaction": "4599"
    },
    {
      "id": 32899,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Griffith Peter H.",
      "reporting_owner_cik": "0001798821",
      "reporting_owner_position": "EVP & CFO",
      "transaction_date": "2024-05-05",
      "transaction_shares": "648",
      "transaction_price": "311.29",
      "transaction_type": "F",
      "shares_after_transaction": "32777"
    },
    {
      "id": 32906,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "REESE DAVID M",
      "reporting_owner_cik": "0001748434",
      "reporting_owner_position": "EVP & Chief Technology Officer",
      "transaction_date": "2024-05-05",
      "transaction_shares": "633",
      "transaction_price": "311.29",
      "transaction_type": "F",
      "shares_after_transaction": "58693"
    },
    {
      "id": 32923,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradway Robert A",
      "reporting_owner_cik": "0001396482",
      "reporting_owner_position": "Chairman, CEO and President",
      "transaction_date": "2024-05-05",
      "transaction_shares": "2220",
      "transaction_price": "311.29",
      "transaction_type": "F",
      "shares_after_transaction": "657281"
    },
    {
      "id": 32930,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Grygiel Nancy A.",
      "reporting_owner_cik": "0001816414",
      "reporting_owner_position": "SVP & CCO",
      "transaction_date": "2024-05-05",
      "transaction_shares": "82",
      "transaction_price": "311.29",
      "transaction_type": "F",
      "shares_after_transaction": "9801"
    },
    {
      "id": 32933,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Miller Derek",
      "reporting_owner_cik": "0001917312",
      "reporting_owner_position": "SVP, Human Resources",
      "transaction_date": "2024-05-05",
      "transaction_shares": "78",
      "transaction_price": "311.29",
      "transaction_type": "F",
      "shares_after_transaction": "8118"
    },
    {
      "id": 50845,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Graham Jonathan P",
      "reporting_owner_cik": "0001365306",
      "reporting_owner_position": "EVP & Gen. Counsel & Secy.",
      "transaction_date": "2024-05-05",
      "transaction_shares": "632",
      "transaction_price": "311.29",
      "transaction_type": "F",
      "shares_after_transaction": "32323"
    },
    {
      "id": 50847,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Gordon Murdo",
      "reporting_owner_cik": "0001642156",
      "reporting_owner_position": "EVP, Global Commercial Ops",
      "transaction_date": "2024-05-05",
      "transaction_shares": "665",
      "transaction_price": "311.29",
      "transaction_type": "F",
      "shares_after_transaction": "49145"
    },
    {
      "id": 50853,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Santos Esteban",
      "reporting_owner_cik": "0001677950",
      "reporting_owner_position": "EVP, Operations",
      "transaction_date": "2024-05-05",
      "transaction_shares": "617",
      "transaction_price": "311.29",
      "transaction_type": "F",
      "shares_after_transaction": "68307"
    },
    {
      "id": 50854,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Khosla Rachna",
      "reporting_owner_cik": "0001881332",
      "reporting_owner_position": "SVP, Business Development",
      "transaction_date": "2024-05-05",
      "transaction_shares": "41",
      "transaction_price": "311.29",
      "transaction_type": "F",
      "shares_after_transaction": "8027"
    },
    {
      "id": 50858,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Busch Matthew C.",
      "reporting_owner_cik": "0001987926",
      "reporting_owner_position": "VP, Finance & CAO",
      "transaction_date": "2024-05-05",
      "transaction_shares": "27",
      "transaction_price": "311.29",
      "transaction_type": "F",
      "shares_after_transaction": "4599"
    },
    {
      "id": 50872,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Griffith Peter H.",
      "reporting_owner_cik": "0001798821",
      "reporting_owner_position": "EVP & CFO",
      "transaction_date": "2024-05-05",
      "transaction_shares": "648",
      "transaction_price": "311.29",
      "transaction_type": "F",
      "shares_after_transaction": "32777"
    },
    {
      "id": 50880,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "REESE DAVID M",
      "reporting_owner_cik": "0001748434",
      "reporting_owner_position": "EVP & Chief Technology Officer",
      "transaction_date": "2024-05-05",
      "transaction_shares": "633",
      "transaction_price": "311.29",
      "transaction_type": "F",
      "shares_after_transaction": "58693"
    },
    {
      "id": 50901,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradway Robert A",
      "reporting_owner_cik": "0001396482",
      "reporting_owner_position": "Chairman, CEO and President",
      "transaction_date": "2024-05-05",
      "transaction_shares": "2220",
      "transaction_price": "311.29",
      "transaction_type": "F",
      "shares_after_transaction": "657281"
    },
    {
      "id": 50911,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Grygiel Nancy A.",
      "reporting_owner_cik": "0001816414",
      "reporting_owner_position": "SVP & CCO",
      "transaction_date": "2024-05-05",
      "transaction_shares": "82",
      "transaction_price": "311.29",
      "transaction_type": "F",
      "shares_after_transaction": "9801"
    },
    {
      "id": 50914,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Miller Derek",
      "reporting_owner_cik": "0001917312",
      "reporting_owner_position": "SVP, Human Resources",
      "transaction_date": "2024-05-05",
      "transaction_shares": "78",
      "transaction_price": "311.29",
      "transaction_type": "F",
      "shares_after_transaction": "8118"
    },
    {
      "id": 32936,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Grygiel Nancy A.",
      "reporting_owner_cik": "0001816414",
      "reporting_owner_position": "SVP & CCO",
      "transaction_date": "2024-05-03",
      "transaction_shares": "2117",
      "transaction_price": "313.0853",
      "transaction_type": "S",
      "shares_after_transaction": "9883"
    },
    {
      "id": 50917,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Grygiel Nancy A.",
      "reporting_owner_cik": "0001816414",
      "reporting_owner_position": "SVP & CCO",
      "transaction_date": "2024-05-03",
      "transaction_shares": "2117",
      "transaction_price": "313.0853",
      "transaction_type": "S",
      "shares_after_transaction": "9883"
    },
    {
      "id": 32873,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Busch Matthew C.",
      "reporting_owner_cik": "0001987926",
      "reporting_owner_position": "VP, Finance & CAO",
      "transaction_date": "2024-05-02",
      "transaction_shares": "27",
      "transaction_price": "277.37",
      "transaction_type": "F",
      "shares_after_transaction": "4626"
    },
    {
      "id": 32879,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Miller Derek",
      "reporting_owner_cik": "0001917312",
      "reporting_owner_position": "SVP, Human Resources",
      "transaction_date": "2024-05-02",
      "transaction_shares": "152",
      "transaction_price": "277.37",
      "transaction_type": "F",
      "shares_after_transaction": "8196"
    },
    {
      "id": 32884,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Khosla Rachna",
      "reporting_owner_cik": "0001881332",
      "reporting_owner_position": "SVP, Business Development",
      "transaction_date": "2024-05-02",
      "transaction_shares": "74",
      "transaction_price": "277.37",
      "transaction_type": "F",
      "shares_after_transaction": "8068"
    },
    {
      "id": 32888,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Santos Esteban",
      "reporting_owner_cik": "0001677950",
      "reporting_owner_position": "EVP, Operations",
      "transaction_date": "2024-05-02",
      "transaction_shares": "606",
      "transaction_price": "277.37",
      "transaction_type": "F",
      "shares_after_transaction": "68924"
    },
    {
      "id": 32893,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Grygiel Nancy A.",
      "reporting_owner_cik": "0001816414",
      "reporting_owner_position": "SVP & CCO",
      "transaction_date": "2024-05-02",
      "transaction_shares": "114",
      "transaction_price": "277.37",
      "transaction_type": "F",
      "shares_after_transaction": "12000"
    },
    {
      "id": 32896,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Gordon Murdo",
      "reporting_owner_cik": "0001642156",
      "reporting_owner_position": "EVP, Global Commercial Ops",
      "transaction_date": "2024-05-02",
      "transaction_shares": "758",
      "transaction_price": "277.37",
      "transaction_type": "F",
      "shares_after_transaction": "49810"
    },
    {
      "id": 32904,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradway Robert A",
      "reporting_owner_cik": "0001396482",
      "reporting_owner_position": "Chairman, CEO and President",
      "transaction_date": "2024-05-02",
      "transaction_shares": "2294",
      "transaction_price": "277.37",
      "transaction_type": "F",
      "shares_after_transaction": "659501"
    },
    {
      "id": 32914,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "REESE DAVID M",
      "reporting_owner_cik": "0001748434",
      "reporting_owner_position": "EVP & Chief Technology Officer",
      "transaction_date": "2024-05-02",
      "transaction_shares": "650",
      "transaction_price": "277.37",
      "transaction_type": "F",
      "shares_after_transaction": "59326"
    },
    {
      "id": 32924,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Graham Jonathan P",
      "reporting_owner_cik": "0001365306",
      "reporting_owner_position": "EVP & Gen. Counsel & Secy.",
      "transaction_date": "2024-05-02",
      "transaction_shares": "591",
      "transaction_price": "277.37",
      "transaction_type": "F",
      "shares_after_transaction": "32955"
    },
    {
      "id": 32934,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Griffith Peter H.",
      "reporting_owner_cik": "0001798821",
      "reporting_owner_position": "EVP & CFO",
      "transaction_date": "2024-05-02",
      "transaction_shares": "682",
      "transaction_price": "277.37",
      "transaction_type": "F",
      "shares_after_transaction": "33425"
    },
    {
      "id": 50844,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Busch Matthew C.",
      "reporting_owner_cik": "0001987926",
      "reporting_owner_position": "VP, Finance & CAO",
      "transaction_date": "2024-05-02",
      "transaction_shares": "27",
      "transaction_price": "277.37",
      "transaction_type": "F",
      "shares_after_transaction": "4626"
    },
    {
      "id": 50850,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Miller Derek",
      "reporting_owner_cik": "0001917312",
      "reporting_owner_position": "SVP, Human Resources",
      "transaction_date": "2024-05-02",
      "transaction_shares": "152",
      "transaction_price": "277.37",
      "transaction_type": "F",
      "shares_after_transaction": "8196"
    },
    {
      "id": 50855,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Khosla Rachna",
      "reporting_owner_cik": "0001881332",
      "reporting_owner_position": "SVP, Business Development",
      "transaction_date": "2024-05-02",
      "transaction_shares": "74",
      "transaction_price": "277.37",
      "transaction_type": "F",
      "shares_after_transaction": "8068"
    },
    {
      "id": 50861,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Santos Esteban",
      "reporting_owner_cik": "0001677950",
      "reporting_owner_position": "EVP, Operations",
      "transaction_date": "2024-05-02",
      "transaction_shares": "606",
      "transaction_price": "277.37",
      "transaction_type": "F",
      "shares_after_transaction": "68924"
    },
    {
      "id": 50866,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Grygiel Nancy A.",
      "reporting_owner_cik": "0001816414",
      "reporting_owner_position": "SVP & CCO",
      "transaction_date": "2024-05-02",
      "transaction_shares": "114",
      "transaction_price": "277.37",
      "transaction_type": "F",
      "shares_after_transaction": "12000"
    },
    {
      "id": 50869,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Gordon Murdo",
      "reporting_owner_cik": "0001642156",
      "reporting_owner_position": "EVP, Global Commercial Ops",
      "transaction_date": "2024-05-02",
      "transaction_shares": "758",
      "transaction_price": "277.37",
      "transaction_type": "F",
      "shares_after_transaction": "49810"
    },
    {
      "id": 50878,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradway Robert A",
      "reporting_owner_cik": "0001396482",
      "reporting_owner_position": "Chairman, CEO and President",
      "transaction_date": "2024-05-02",
      "transaction_shares": "2294",
      "transaction_price": "277.37",
      "transaction_type": "F",
      "shares_after_transaction": "659501"
    },
    {
      "id": 50889,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "REESE DAVID M",
      "reporting_owner_cik": "0001748434",
      "reporting_owner_position": "EVP & Chief Technology Officer",
      "transaction_date": "2024-05-02",
      "transaction_shares": "650",
      "transaction_price": "277.37",
      "transaction_type": "F",
      "shares_after_transaction": "59326"
    },
    {
      "id": 50903,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Graham Jonathan P",
      "reporting_owner_cik": "0001365306",
      "reporting_owner_position": "EVP & Gen. Counsel & Secy.",
      "transaction_date": "2024-05-02",
      "transaction_shares": "591",
      "transaction_price": "277.37",
      "transaction_type": "F",
      "shares_after_transaction": "32955"
    },
    {
      "id": 50915,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Griffith Peter H.",
      "reporting_owner_cik": "0001798821",
      "reporting_owner_position": "EVP & CFO",
      "transaction_date": "2024-05-02",
      "transaction_shares": "682",
      "transaction_price": "277.37",
      "transaction_type": "F",
      "shares_after_transaction": "33425"
    },
    {
      "id": 32872,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Griffith Peter H.",
      "reporting_owner_cik": "0001798821",
      "reporting_owner_position": "EVP & CFO",
      "transaction_date": "2024-04-30",
      "transaction_shares": "603",
      "transaction_price": "276.38",
      "transaction_type": "F",
      "shares_after_transaction": "34107"
    },
    {
      "id": 32878,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "REESE DAVID M",
      "reporting_owner_cik": "0001748434",
      "reporting_owner_position": "EVP & Chief Technology Officer",
      "transaction_date": "2024-04-30",
      "transaction_shares": "690",
      "transaction_price": "276.38",
      "transaction_type": "F",
      "shares_after_transaction": "59976"
    },
    {
      "id": 32880,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Busch Matthew C.",
      "reporting_owner_cik": "0001987926",
      "reporting_owner_position": "VP, Finance & CAO",
      "transaction_date": "2024-04-30",
      "transaction_shares": "17",
      "transaction_price": "276.38",
      "transaction_type": "F",
      "shares_after_transaction": "4653"
    },
    {
      "id": 32894,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Gordon Murdo",
      "reporting_owner_cik": "0001642156",
      "reporting_owner_position": "EVP, Global Commercial Ops",
      "transaction_date": "2024-04-30",
      "transaction_shares": "753",
      "transaction_price": "276.38",
      "transaction_type": "F",
      "shares_after_transaction": "50568"
    },
    {
      "id": 32895,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Miller Derek",
      "reporting_owner_cik": "0001917312",
      "reporting_owner_position": "SVP, Human Resources",
      "transaction_date": "2024-04-30",
      "transaction_shares": "71",
      "transaction_price": "276.38",
      "transaction_type": "F",
      "shares_after_transaction": "8348"
    },
    {
      "id": 32897,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradway Robert A",
      "reporting_owner_cik": "0001396482",
      "reporting_owner_position": "Chairman, CEO and President",
      "transaction_date": "2024-04-30",
      "transaction_shares": "2282",
      "transaction_price": "276.38",
      "transaction_type": "F",
      "shares_after_transaction": "661795"
    },
    {
      "id": 32900,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Graham Jonathan P",
      "reporting_owner_cik": "0001365306",
      "reporting_owner_position": "EVP & Gen. Counsel & Secy.",
      "transaction_date": "2024-04-30",
      "transaction_shares": "686",
      "transaction_price": "276.38",
      "transaction_type": "F",
      "shares_after_transaction": "33546"
    },
    {
      "id": 32901,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Khosla Rachna",
      "reporting_owner_cik": "0001881332",
      "reporting_owner_position": "SVP, Business Development",
      "transaction_date": "2024-04-30",
      "transaction_shares": "48",
      "transaction_price": "276.38",
      "transaction_type": "F",
      "shares_after_transaction": "8142"
    },
    {
      "id": 32911,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Santos Esteban",
      "reporting_owner_cik": "0001677950",
      "reporting_owner_position": "EVP, Operations",
      "transaction_date": "2024-04-30",
      "transaction_shares": "683",
      "transaction_price": "276.38",
      "transaction_type": "F",
      "shares_after_transaction": "69530"
    },
    {
      "id": 32912,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Grygiel Nancy A.",
      "reporting_owner_cik": "0001816414",
      "reporting_owner_position": "SVP & CCO",
      "transaction_date": "2024-04-30",
      "transaction_shares": "106",
      "transaction_price": "276.38",
      "transaction_type": "F",
      "shares_after_transaction": "12114"
    },
    {
      "id": 50843,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Griffith Peter H.",
      "reporting_owner_cik": "0001798821",
      "reporting_owner_position": "EVP & CFO",
      "transaction_date": "2024-04-30",
      "transaction_shares": "603",
      "transaction_price": "276.38",
      "transaction_type": "F",
      "shares_after_transaction": "34107"
    },
    {
      "id": 50849,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "REESE DAVID M",
      "reporting_owner_cik": "0001748434",
      "reporting_owner_position": "EVP & Chief Technology Officer",
      "transaction_date": "2024-04-30",
      "transaction_shares": "690",
      "transaction_price": "276.38",
      "transaction_type": "F",
      "shares_after_transaction": "59976"
    },
    {
      "id": 50851,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Busch Matthew C.",
      "reporting_owner_cik": "0001987926",
      "reporting_owner_position": "VP, Finance & CAO",
      "transaction_date": "2024-04-30",
      "transaction_shares": "17",
      "transaction_price": "276.38",
      "transaction_type": "F",
      "shares_after_transaction": "4653"
    },
    {
      "id": 50867,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Gordon Murdo",
      "reporting_owner_cik": "0001642156",
      "reporting_owner_position": "EVP, Global Commercial Ops",
      "transaction_date": "2024-04-30",
      "transaction_shares": "753",
      "transaction_price": "276.38",
      "transaction_type": "F",
      "shares_after_transaction": "50568"
    },
    {
      "id": 50868,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Miller Derek",
      "reporting_owner_cik": "0001917312",
      "reporting_owner_position": "SVP, Human Resources",
      "transaction_date": "2024-04-30",
      "transaction_shares": "71",
      "transaction_price": "276.38",
      "transaction_type": "F",
      "shares_after_transaction": "8348"
    },
    {
      "id": 50870,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradway Robert A",
      "reporting_owner_cik": "0001396482",
      "reporting_owner_position": "Chairman, CEO and President",
      "transaction_date": "2024-04-30",
      "transaction_shares": "2282",
      "transaction_price": "276.38",
      "transaction_type": "F",
      "shares_after_transaction": "661795"
    },
    {
      "id": 50874,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Graham Jonathan P",
      "reporting_owner_cik": "0001365306",
      "reporting_owner_position": "EVP & Gen. Counsel & Secy.",
      "transaction_date": "2024-04-30",
      "transaction_shares": "686",
      "transaction_price": "276.38",
      "transaction_type": "F",
      "shares_after_transaction": "33546"
    },
    {
      "id": 50875,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Khosla Rachna",
      "reporting_owner_cik": "0001881332",
      "reporting_owner_position": "SVP, Business Development",
      "transaction_date": "2024-04-30",
      "transaction_shares": "48",
      "transaction_price": "276.38",
      "transaction_type": "F",
      "shares_after_transaction": "8142"
    },
    {
      "id": 50886,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Santos Esteban",
      "reporting_owner_cik": "0001677950",
      "reporting_owner_position": "EVP, Operations",
      "transaction_date": "2024-04-30",
      "transaction_shares": "683",
      "transaction_price": "276.38",
      "transaction_type": "F",
      "shares_after_transaction": "69530"
    },
    {
      "id": 50887,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Grygiel Nancy A.",
      "reporting_owner_cik": "0001816414",
      "reporting_owner_position": "SVP & CCO",
      "transaction_date": "2024-04-30",
      "transaction_shares": "106",
      "transaction_price": "276.38",
      "transaction_type": "F",
      "shares_after_transaction": "12114"
    },
    {
      "id": 7588,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Griffith Peter H.",
      "reporting_owner_cik": "0001798821",
      "reporting_owner_position": "EVP & CFO",
      "transaction_date": "2024-03-18",
      "transaction_shares": "5168",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "34710"
    },
    {
      "id": 7589,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Khosla Rachna",
      "reporting_owner_cik": "0001881332",
      "reporting_owner_position": "SVP, Business Development",
      "transaction_date": "2024-03-18",
      "transaction_shares": "438",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "8190"
    },
    {
      "id": 7591,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradway Robert A",
      "reporting_owner_cik": "0001396482",
      "reporting_owner_position": "Chairman, CEO and President",
      "transaction_date": "2024-03-18",
      "transaction_shares": "20560",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "664077"
    },
    {
      "id": 7593,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Busch Matthew C.",
      "reporting_owner_cik": "0001987926",
      "reporting_owner_position": "VP, Finance & CAO",
      "transaction_date": "2024-03-18",
      "transaction_shares": "146",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "4670"
    },
    {
      "id": 7594,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Miller Derek",
      "reporting_owner_cik": "0001917312",
      "reporting_owner_position": "SVP, Human Resources",
      "transaction_date": "2024-03-18",
      "transaction_shares": "475",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "8419"
    },
    {
      "id": 7597,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Santos Esteban",
      "reporting_owner_cik": "0001677950",
      "reporting_owner_position": "EVP, Operations",
      "transaction_date": "2024-03-18",
      "transaction_shares": "6137",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "70213"
    },
    {
      "id": 7601,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Graham Jonathan P",
      "reporting_owner_cik": "0001365306",
      "reporting_owner_position": "EVP & Gen. Counsel & Secy.",
      "transaction_date": "2024-03-18",
      "transaction_shares": "5879",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "34232"
    },
    {
      "id": 7603,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "REESE DAVID M",
      "reporting_owner_cik": "0001748434",
      "reporting_owner_position": "EVP & Chief Technology Officer",
      "transaction_date": "2024-03-18",
      "transaction_shares": "6202",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "60666"
    },
    {
      "id": 7606,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Grygiel Nancy A.",
      "reporting_owner_cik": "0001816414",
      "reporting_owner_position": "SVP & CCO",
      "transaction_date": "2024-03-18",
      "transaction_shares": "703",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "12220"
    },
    {
      "id": 7608,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Gordon Murdo",
      "reporting_owner_cik": "0001642156",
      "reporting_owner_position": "EVP, Global Commercial Ops",
      "transaction_date": "2024-03-18",
      "transaction_shares": "6461",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "51321"
    },
    {
      "id": 18752,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Griffith Peter H.",
      "reporting_owner_cik": "0001798821",
      "reporting_owner_position": "EVP & CFO",
      "transaction_date": "2024-03-18",
      "transaction_shares": "5168",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "34710"
    },
    {
      "id": 18753,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Khosla Rachna",
      "reporting_owner_cik": "0001881332",
      "reporting_owner_position": "SVP, Business Development",
      "transaction_date": "2024-03-18",
      "transaction_shares": "438",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "8190"
    },
    {
      "id": 18755,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradway Robert A",
      "reporting_owner_cik": "0001396482",
      "reporting_owner_position": "Chairman, CEO and President",
      "transaction_date": "2024-03-18",
      "transaction_shares": "20560",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "664077"
    },
    {
      "id": 18757,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Busch Matthew C.",
      "reporting_owner_cik": "0001987926",
      "reporting_owner_position": "VP, Finance & CAO",
      "transaction_date": "2024-03-18",
      "transaction_shares": "146",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "4670"
    },
    {
      "id": 18758,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Miller Derek",
      "reporting_owner_cik": "0001917312",
      "reporting_owner_position": "SVP, Human Resources",
      "transaction_date": "2024-03-18",
      "transaction_shares": "475",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "8419"
    },
    {
      "id": 18761,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Santos Esteban",
      "reporting_owner_cik": "0001677950",
      "reporting_owner_position": "EVP, Operations",
      "transaction_date": "2024-03-18",
      "transaction_shares": "6137",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "70213"
    },
    {
      "id": 18765,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Graham Jonathan P",
      "reporting_owner_cik": "0001365306",
      "reporting_owner_position": "EVP & Gen. Counsel & Secy.",
      "transaction_date": "2024-03-18",
      "transaction_shares": "5879",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "34232"
    },
    {
      "id": 18767,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "REESE DAVID M",
      "reporting_owner_cik": "0001748434",
      "reporting_owner_position": "EVP & Chief Technology Officer",
      "transaction_date": "2024-03-18",
      "transaction_shares": "6202",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "60666"
    },
    {
      "id": 18770,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Grygiel Nancy A.",
      "reporting_owner_cik": "0001816414",
      "reporting_owner_position": "SVP & CCO",
      "transaction_date": "2024-03-18",
      "transaction_shares": "703",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "12220"
    },
    {
      "id": 18772,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Gordon Murdo",
      "reporting_owner_cik": "0001642156",
      "reporting_owner_position": "EVP, Global Commercial Ops",
      "transaction_date": "2024-03-18",
      "transaction_shares": "6461",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "51321"
    },
    {
      "id": 32877,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Griffith Peter H.",
      "reporting_owner_cik": "0001798821",
      "reporting_owner_position": "EVP & CFO",
      "transaction_date": "2024-03-18",
      "transaction_shares": "5168",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "34710"
    },
    {
      "id": 32886,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Khosla Rachna",
      "reporting_owner_cik": "0001881332",
      "reporting_owner_position": "SVP, Business Development",
      "transaction_date": "2024-03-18",
      "transaction_shares": "438",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "8190"
    },
    {
      "id": 32890,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradway Robert A",
      "reporting_owner_cik": "0001396482",
      "reporting_owner_position": "Chairman, CEO and President",
      "transaction_date": "2024-03-18",
      "transaction_shares": "20560",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "664077"
    },
    {
      "id": 32892,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Busch Matthew C.",
      "reporting_owner_cik": "0001987926",
      "reporting_owner_position": "VP, Finance & CAO",
      "transaction_date": "2024-03-18",
      "transaction_shares": "146",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "4670"
    },
    {
      "id": 32898,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Miller Derek",
      "reporting_owner_cik": "0001917312",
      "reporting_owner_position": "SVP, Human Resources",
      "transaction_date": "2024-03-18",
      "transaction_shares": "475",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "8419"
    },
    {
      "id": 32908,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Santos Esteban",
      "reporting_owner_cik": "0001677950",
      "reporting_owner_position": "EVP, Operations",
      "transaction_date": "2024-03-18",
      "transaction_shares": "6137",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "70213"
    },
    {
      "id": 32917,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Graham Jonathan P",
      "reporting_owner_cik": "0001365306",
      "reporting_owner_position": "EVP & Gen. Counsel & Secy.",
      "transaction_date": "2024-03-18",
      "transaction_shares": "5879",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "34232"
    },
    {
      "id": 32919,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "REESE DAVID M",
      "reporting_owner_cik": "0001748434",
      "reporting_owner_position": "EVP & Chief Technology Officer",
      "transaction_date": "2024-03-18",
      "transaction_shares": "6202",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "60666"
    },
    {
      "id": 32929,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Grygiel Nancy A.",
      "reporting_owner_cik": "0001816414",
      "reporting_owner_position": "SVP & CCO",
      "transaction_date": "2024-03-18",
      "transaction_shares": "703",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "12220"
    },
    {
      "id": 32935,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Gordon Murdo",
      "reporting_owner_cik": "0001642156",
      "reporting_owner_position": "EVP, Global Commercial Ops",
      "transaction_date": "2024-03-18",
      "transaction_shares": "6461",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "51321"
    },
    {
      "id": 50848,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Griffith Peter H.",
      "reporting_owner_cik": "0001798821",
      "reporting_owner_position": "EVP & CFO",
      "transaction_date": "2024-03-18",
      "transaction_shares": "5168",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "34710"
    },
    {
      "id": 50859,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Khosla Rachna",
      "reporting_owner_cik": "0001881332",
      "reporting_owner_position": "SVP, Business Development",
      "transaction_date": "2024-03-18",
      "transaction_shares": "438",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "8190"
    },
    {
      "id": 50863,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradway Robert A",
      "reporting_owner_cik": "0001396482",
      "reporting_owner_position": "Chairman, CEO and President",
      "transaction_date": "2024-03-18",
      "transaction_shares": "20560",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "664077"
    },
    {
      "id": 50865,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Busch Matthew C.",
      "reporting_owner_cik": "0001987926",
      "reporting_owner_position": "VP, Finance & CAO",
      "transaction_date": "2024-03-18",
      "transaction_shares": "146",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "4670"
    },
    {
      "id": 50871,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Miller Derek",
      "reporting_owner_cik": "0001917312",
      "reporting_owner_position": "SVP, Human Resources",
      "transaction_date": "2024-03-18",
      "transaction_shares": "475",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "8419"
    },
    {
      "id": 50882,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Santos Esteban",
      "reporting_owner_cik": "0001677950",
      "reporting_owner_position": "EVP, Operations",
      "transaction_date": "2024-03-18",
      "transaction_shares": "6137",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "70213"
    },
    {
      "id": 50893,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Graham Jonathan P",
      "reporting_owner_cik": "0001365306",
      "reporting_owner_position": "EVP & Gen. Counsel & Secy.",
      "transaction_date": "2024-03-18",
      "transaction_shares": "5879",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "34232"
    },
    {
      "id": 50896,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "REESE DAVID M",
      "reporting_owner_cik": "0001748434",
      "reporting_owner_position": "EVP & Chief Technology Officer",
      "transaction_date": "2024-03-18",
      "transaction_shares": "6202",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "60666"
    },
    {
      "id": 50910,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Grygiel Nancy A.",
      "reporting_owner_cik": "0001816414",
      "reporting_owner_position": "SVP & CCO",
      "transaction_date": "2024-03-18",
      "transaction_shares": "703",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "12220"
    },
    {
      "id": 50916,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Gordon Murdo",
      "reporting_owner_cik": "0001642156",
      "reporting_owner_position": "EVP, Global Commercial Ops",
      "transaction_date": "2024-03-18",
      "transaction_shares": "6461",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "51321"
    },
    {
      "id": 7590,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Santos Esteban",
      "reporting_owner_cik": "0001677950",
      "reporting_owner_position": "EVP, Operations",
      "transaction_date": "2024-03-06",
      "transaction_shares": "12278",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "76125"
    },
    {
      "id": 7592,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Graham Jonathan P",
      "reporting_owner_cik": "0001365306",
      "reporting_owner_position": "EVP & Gen. Counsel & Secy.",
      "transaction_date": "2024-03-06",
      "transaction_shares": "11760",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "39925"
    },
    {
      "id": 7595,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "REESE DAVID M",
      "reporting_owner_cik": "0001748434",
      "reporting_owner_position": "EVP & Chief Technology Officer",
      "transaction_date": "2024-03-06",
      "transaction_shares": "12407",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "66653"
    },
    {
      "id": 7596,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradway Robert A",
      "reporting_owner_cik": "0001396482",
      "reporting_owner_position": "Chairman, CEO and President",
      "transaction_date": "2024-03-06",
      "transaction_shares": "41133",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "683910"
    },
    {
      "id": 7598,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Grygiel Nancy A.",
      "reporting_owner_cik": "0001816414",
      "reporting_owner_position": "SVP & CCO",
      "transaction_date": "2024-03-06",
      "transaction_shares": "1954",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "12866"
    },
    {
      "id": 7599,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Gordon Murdo",
      "reporting_owner_cik": "0001642156",
      "reporting_owner_position": "EVP, Global Commercial Ops",
      "transaction_date": "2024-03-06",
      "transaction_shares": "12924",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "57569"
    },
    {
      "id": 7600,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Busch Matthew C.",
      "reporting_owner_cik": "0001987926",
      "reporting_owner_position": "VP, Finance & CAO",
      "transaction_date": "2024-03-06",
      "transaction_shares": "418",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "4799"
    },
    {
      "id": 7602,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Griffith Peter H.",
      "reporting_owner_cik": "0001798821",
      "reporting_owner_position": "EVP & CFO",
      "transaction_date": "2024-03-06",
      "transaction_shares": "10338",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "39250"
    },
    {
      "id": 7604,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Miller Derek",
      "reporting_owner_cik": "0001917312",
      "reporting_owner_position": "SVP, Human Resources",
      "transaction_date": "2024-03-06",
      "transaction_shares": "1311",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8863"
    },
    {
      "id": 7607,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Khosla Rachna",
      "reporting_owner_cik": "0001881332",
      "reporting_owner_position": "SVP, Business Development",
      "transaction_date": "2024-03-06",
      "transaction_shares": "1256",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8597"
    },
    {
      "id": 18754,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Santos Esteban",
      "reporting_owner_cik": "0001677950",
      "reporting_owner_position": "EVP, Operations",
      "transaction_date": "2024-03-06",
      "transaction_shares": "12278",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "76125"
    },
    {
      "id": 18756,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Graham Jonathan P",
      "reporting_owner_cik": "0001365306",
      "reporting_owner_position": "EVP & Gen. Counsel & Secy.",
      "transaction_date": "2024-03-06",
      "transaction_shares": "11760",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "39925"
    },
    {
      "id": 18759,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "REESE DAVID M",
      "reporting_owner_cik": "0001748434",
      "reporting_owner_position": "EVP & Chief Technology Officer",
      "transaction_date": "2024-03-06",
      "transaction_shares": "12407",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "66653"
    },
    {
      "id": 18760,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradway Robert A",
      "reporting_owner_cik": "0001396482",
      "reporting_owner_position": "Chairman, CEO and President",
      "transaction_date": "2024-03-06",
      "transaction_shares": "41133",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "683910"
    },
    {
      "id": 18762,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Grygiel Nancy A.",
      "reporting_owner_cik": "0001816414",
      "reporting_owner_position": "SVP & CCO",
      "transaction_date": "2024-03-06",
      "transaction_shares": "1954",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "12866"
    },
    {
      "id": 18763,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Gordon Murdo",
      "reporting_owner_cik": "0001642156",
      "reporting_owner_position": "EVP, Global Commercial Ops",
      "transaction_date": "2024-03-06",
      "transaction_shares": "12924",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "57569"
    },
    {
      "id": 18764,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Busch Matthew C.",
      "reporting_owner_cik": "0001987926",
      "reporting_owner_position": "VP, Finance & CAO",
      "transaction_date": "2024-03-06",
      "transaction_shares": "418",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "4799"
    },
    {
      "id": 18766,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Griffith Peter H.",
      "reporting_owner_cik": "0001798821",
      "reporting_owner_position": "EVP & CFO",
      "transaction_date": "2024-03-06",
      "transaction_shares": "10338",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "39250"
    },
    {
      "id": 18768,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Miller Derek",
      "reporting_owner_cik": "0001917312",
      "reporting_owner_position": "SVP, Human Resources",
      "transaction_date": "2024-03-06",
      "transaction_shares": "1311",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8863"
    },
    {
      "id": 18771,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Khosla Rachna",
      "reporting_owner_cik": "0001881332",
      "reporting_owner_position": "SVP, Business Development",
      "transaction_date": "2024-03-06",
      "transaction_shares": "1256",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8597"
    },
    {
      "id": 32889,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Santos Esteban",
      "reporting_owner_cik": "0001677950",
      "reporting_owner_position": "EVP, Operations",
      "transaction_date": "2024-03-06",
      "transaction_shares": "12278",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "76125"
    },
    {
      "id": 32891,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Graham Jonathan P",
      "reporting_owner_cik": "0001365306",
      "reporting_owner_position": "EVP & Gen. Counsel & Secy.",
      "transaction_date": "2024-03-06",
      "transaction_shares": "11760",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "39925"
    },
    {
      "id": 32905,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "REESE DAVID M",
      "reporting_owner_cik": "0001748434",
      "reporting_owner_position": "EVP & Chief Technology Officer",
      "transaction_date": "2024-03-06",
      "transaction_shares": "12407",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "66653"
    },
    {
      "id": 32907,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradway Robert A",
      "reporting_owner_cik": "0001396482",
      "reporting_owner_position": "Chairman, CEO and President",
      "transaction_date": "2024-03-06",
      "transaction_shares": "41133",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "683910"
    },
    {
      "id": 32910,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Grygiel Nancy A.",
      "reporting_owner_cik": "0001816414",
      "reporting_owner_position": "SVP & CCO",
      "transaction_date": "2024-03-06",
      "transaction_shares": "1954",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "12866"
    },
    {
      "id": 32913,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Gordon Murdo",
      "reporting_owner_cik": "0001642156",
      "reporting_owner_position": "EVP, Global Commercial Ops",
      "transaction_date": "2024-03-06",
      "transaction_shares": "12924",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "57569"
    },
    {
      "id": 32915,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Busch Matthew C.",
      "reporting_owner_cik": "0001987926",
      "reporting_owner_position": "VP, Finance & CAO",
      "transaction_date": "2024-03-06",
      "transaction_shares": "418",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "4799"
    },
    {
      "id": 32918,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Griffith Peter H.",
      "reporting_owner_cik": "0001798821",
      "reporting_owner_position": "EVP & CFO",
      "transaction_date": "2024-03-06",
      "transaction_shares": "10338",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "39250"
    },
    {
      "id": 32921,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Miller Derek",
      "reporting_owner_cik": "0001917312",
      "reporting_owner_position": "SVP, Human Resources",
      "transaction_date": "2024-03-06",
      "transaction_shares": "1311",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8863"
    },
    {
      "id": 32932,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Khosla Rachna",
      "reporting_owner_cik": "0001881332",
      "reporting_owner_position": "SVP, Business Development",
      "transaction_date": "2024-03-06",
      "transaction_shares": "1256",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8597"
    },
    {
      "id": 50862,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Santos Esteban",
      "reporting_owner_cik": "0001677950",
      "reporting_owner_position": "EVP, Operations",
      "transaction_date": "2024-03-06",
      "transaction_shares": "12278",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "76125"
    },
    {
      "id": 50864,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Graham Jonathan P",
      "reporting_owner_cik": "0001365306",
      "reporting_owner_position": "EVP & Gen. Counsel & Secy.",
      "transaction_date": "2024-03-06",
      "transaction_shares": "11760",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "39925"
    },
    {
      "id": 50879,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "REESE DAVID M",
      "reporting_owner_cik": "0001748434",
      "reporting_owner_position": "EVP & Chief Technology Officer",
      "transaction_date": "2024-03-06",
      "transaction_shares": "12407",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "66653"
    },
    {
      "id": 50881,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradway Robert A",
      "reporting_owner_cik": "0001396482",
      "reporting_owner_position": "Chairman, CEO and President",
      "transaction_date": "2024-03-06",
      "transaction_shares": "41133",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "683910"
    },
    {
      "id": 50884,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Grygiel Nancy A.",
      "reporting_owner_cik": "0001816414",
      "reporting_owner_position": "SVP & CCO",
      "transaction_date": "2024-03-06",
      "transaction_shares": "1954",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "12866"
    },
    {
      "id": 50888,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Gordon Murdo",
      "reporting_owner_cik": "0001642156",
      "reporting_owner_position": "EVP, Global Commercial Ops",
      "transaction_date": "2024-03-06",
      "transaction_shares": "12924",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "57569"
    },
    {
      "id": 50890,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Busch Matthew C.",
      "reporting_owner_cik": "0001987926",
      "reporting_owner_position": "VP, Finance & CAO",
      "transaction_date": "2024-03-06",
      "transaction_shares": "418",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "4799"
    },
    {
      "id": 50894,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Griffith Peter H.",
      "reporting_owner_cik": "0001798821",
      "reporting_owner_position": "EVP & CFO",
      "transaction_date": "2024-03-06",
      "transaction_shares": "10338",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "39250"
    },
    {
      "id": 50899,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Miller Derek",
      "reporting_owner_cik": "0001917312",
      "reporting_owner_position": "SVP, Human Resources",
      "transaction_date": "2024-03-06",
      "transaction_shares": "1311",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8863"
    },
    {
      "id": 50913,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Khosla Rachna",
      "reporting_owner_cik": "0001881332",
      "reporting_owner_position": "SVP, Business Development",
      "transaction_date": "2024-03-06",
      "transaction_shares": "1256",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8597"
    },
    {
      "id": 1215,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradner James E.",
      "reporting_owner_cik": "0002005159",
      "reporting_owner_position": "EVP, R&D, & Chief Sci. Officer",
      "transaction_date": "2024-02-09",
      "transaction_shares": "8587",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8587"
    },
    {
      "id": 7605,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradner James E.",
      "reporting_owner_cik": "0002005159",
      "reporting_owner_position": "EVP, R&D, & Chief Sci. Officer",
      "transaction_date": "2024-02-09",
      "transaction_shares": "8587",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8587"
    },
    {
      "id": 18769,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradner James E.",
      "reporting_owner_cik": "0002005159",
      "reporting_owner_position": "EVP, R&D, & Chief Sci. Officer",
      "transaction_date": "2024-02-09",
      "transaction_shares": "8587",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8587"
    },
    {
      "id": 32926,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradner James E.",
      "reporting_owner_cik": "0002005159",
      "reporting_owner_position": "EVP, R&D, & Chief Sci. Officer",
      "transaction_date": "2024-02-09",
      "transaction_shares": "8587",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8587"
    },
    {
      "id": 50905,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradner James E.",
      "reporting_owner_cik": "0002005159",
      "reporting_owner_position": "EVP, R&D, & Chief Sci. Officer",
      "transaction_date": "2024-02-09",
      "transaction_shares": "8587",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8587"
    }
  ]
}